Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06413316 · ClinicalTrials.gov registry record
ABC-CT Pre-School Feasibility Study
A clinical trial of Autism Spectrum Disorder, sponsored by Yale University.
- Completed
- Registry status
- 50
- Enrollment target
- 5
- Study locations
NCT06413316 is a study of Autism Spectrum Disorder that has completed, run by Yale University. The registered enrollment target is 50 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (63% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT06413316, a study of Autism Spectrum Disorder, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a multicenter study that aims to determine whether the EEG and ET experiments studied in the ABC-CT Phase 1 and ABC-CT Confirmation studies can be successfully used with 3-5-year-old children and to determine the viability of these measures as potential biomarkers in 3-5-year-old children with ASD. Blood (DNA) samples will be collected from participants with ASD and biological parents for future genomic analyses, and raw, processed, and analyzed data will be shared to create a community resource accessible for use by all qualified investigators. These objectives are designed to advance the long term objective of developing promising biomarkers via the FDA Biomarker Qualification Program. This feasibility study aims to enroll 25 ASD and 25 TD eligible participants who are 3-5 years old.
Conditions Studied
Study Locations (5)
California
- Children's Hospital Los Angeles - Los Angeles
Connecticut
- Yale Child Study Center - New Haven
Massachusetts
- Boston Children's Hospital - Boston
North Carolina
- Duke University - Durham
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-07-02 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06413316
The ClinicalTrials.gov registry entry for NCT06413316 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (63% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT06413316 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Connecticut, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06413316 about?
NCT06413316 is a clinical study titled "ABC-CT Pre-School Feasibility Study". This is a multicenter study that aims to determine whether the EEG and ET experiments studied in the ABC-CT Phase 1 and ABC-CT Confirmation studies can be successfully used with 3-5-year-old children and to determine the viability of these measures as potential biomarkers in 3-5-year-old children wi...
What is the current status of trial NCT06413316?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2024-07-02. Estimated completion is 2025-06-30.
What conditions does trial NCT06413316 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder.
Who is sponsoring clinical trial NCT06413316?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06413316 being conducted?
This trial has 5 study locations across California, Connecticut, Massachusetts, North Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.